Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: A randomized placebo-controlled trial-Reference-Cited by-同舟云学术

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: A randomized placebo-controlled trial

Published:2004-11-24 Issue:6 Volume:40 Page:1379-1386
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Färkkilä Martti,Karvonen Anna-Liisa,Nurmi Heimo,Nuutinen Hannu,Taavitsainen Matti,Pikkarainen Pekka,Kärkkäinen Päivi

Funder

Mary and Georg C. Ehrnrooth Foundation

Orion Pharma, Finland (metronidazole, Trikozol)

Leiras Finland (ursodeoxycholic acid, Adursal)

Publisher

Wiley

Subject

Hepatology

Reference44 articles.

1. Primary sclerosing cholangitis;Angulo;HEPATOLOGY,1999

2. Primary sclerosing cholangitis;Lee;N Engl J Med,1995

3. Vierling JM Hepatobiliary complications of ulcerative colitis and Crohn's disease Zakim D Boyer TD Hepatology. A Textbook of Liver Disease 2 4th ed. Philadelphia, PA Saunders 2003 1221 1272

4. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations;Spurkland;Tissue Antigens,1999

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications;Medical Review;2024-07-01

2. Therapeutic manipulation of the microbiome in liver disease;Hepatology;2024-06-26

3. Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis;BMC Medical Genomics;2024-06-11

4. The new definition of dominant stricture in primary sclerosing cholangitis: Prevalence and clinical significance;Liver International;2024-06-06

5. New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: a drug Mendelian randomization study;2024-04-25